Anticancer Drugs Course
This course equips oncology professionals with practical skills to master first-line EGFR TKI strategies for EGFR-mutated NSCLC. Learners will manage toxicities effectively, handle resistance challenges, optimise patient outcomes, and communicate treatment plans clearly using evidence-based approaches.

flexible workload from 4 to 360h
valid certificate in your country
What will I learn?
Gain a practical overview of first-line systemic treatments for EGFR-mutated NSCLC, covering targeted therapy, chemo-immunotherapy, and chemotherapy. Master drug mechanisms, dosing schedules, toxicity management, resistance patterns, second-line choices, monitoring protocols, and clear patient communication for confident decisions.
Elevify advantages
Develop skills
- Select EGFR TKI treatments using latest trial data.
- Plan imaging, re-biopsy, and liquid biopsy for resistance.
- Match resistance to targeted therapy, chemo, or trials.
- Prevent and manage EGFR TKI rash, diarrhoea, ILD, and cytopenias.
- Counsel patients clearly on goals, side effects, and progression.
Suggested summary
Before starting, you can change the chapters and workload. Choose which chapter to start with. Add or remove chapters. Increase or decrease the course workload.What our students say
FAQs
Who is Elevify? How does it work?
Do the courses have certificates?
Are the courses free?
What is the course workload?
What are the courses like?
How do the courses work?
What is the duration of the courses?
What is the cost or price of the courses?
What is an EAD or online course and how does it work?
PDF Course